Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward α- And β-substrate lipoproteins

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1646, Issue 1-2, 2003, Pages 164-172

  Vickaryous, Nicola K ^a,b   Teh, Evelyn M ^a,c   Stewart, Bruce ^a   Dolphin, Peter J ^a   Too, Catherine K L ^a   McLeod, Roger S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cholesterol esterification; Enzyme; Lipoprotein; Phosphatidylcholine

Indexed keywords

AMINO ACID DERIVATIVE; APOLIPOPROTEIN A1; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MUTANT PROTEIN; PHOSPHATIDYLCHOLINE; AMINO ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SECRETION; CELL STRAIN COS7; CELL TRANSFER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; GENE DELETION; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; PROTEIN SYNTHESIS; WESTERN BLOTTING; WILD TYPE; ANIMAL; CATALYSIS; CELL STRAIN COS1; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM; SITE DIRECTED MUTAGENESIS;

AMINO ACIDS; ANIMALS; CATALYSIS; COS CELLS; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MUTAGENESIS, SITE-DIRECTED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 0041620594     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00005-0     Document Type: Article

References (38)

1. Jonas A. Lecithin:cholesterol acyltransferase. Biochim. Biophys. Acta. 1529:2000;245-256.
2. McLean J., Fielding C., Drayna D., Dieplinger H., Baer B., Kohr W., Henzel W., Lawn R. Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc. Natl. Acad. Sci. USA. 83:1986;2335-2339.
3. Hill J., O K., Wang X., Paranjape S., Dimitrijevich D., Lacko A., Pritchard H. Expression and characterization of recombinant human lecithin:cholesterol acyltransferase. J. Lipid Res. 34:1993;1245-1251.
4. Jin L., Lee Y., Jonas A. Biochemical and biophysical characterization of human recombinant lecithin:cholesterol acyltransferase. J. Lipid Res. 38:1997;1085-1093.
5. Miller K., Wang J., Sorci-Thomas M., Anderson R., Parks J. Glycosylation structure and enzyme activity of lecithin:cholesterol acyltransferase from human plasma, HepG2 cells, and baculoviral and Chinese hamster ovary cell expression systems. J. Lipid Res. 37:1996;551-561.
6. Lacko A., Reason A., Nuckolls C., Kudchodkar B., Nair M., Sundarrajan G., Pritchard H., Morris H., Dell A. Characterization of recombinant human plasma lecithin:cholesterol acyltransferase (LCAT): N-linked carbohydrate structures and catalytic properties. J. Lipid Res. 39:1998;807-820.
7. Jaeger K., Dijkstra B., Reetz M. Bacterial biocatalysts: molecular biology, three-dimensional structures, and biotechnological applications of lipases. Annu. Rev. Microbiol. 53:1999;315-351.
8. Yang C., Manoogian D., Pao Q., Lee F., Knapp R., Gotto A. Jr., Pownall H. Lecithin:cholesterol acyltransferase functional regions and a structural model of the enzyme. J. Biol. Chem. 262:1987;3086-3091.
9. Jennens M., Lowe M. A surface loop covering the active site of human pancreatic lipase influences interfacial activation and lipid binding. J. Biol. Chem. 269:1994;25470-25474.
10. Dugi K., Dichek H., Talley G., Brewer H. Jr., Santamarina-Fojo S. Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates. J. Biol. Chem. 267:1992;25086-25091.
11. Cygler M., Schrag J. Structure as basis for understanding interfacial properties of lipases. Methods Enzymol. 284:1997;3-27.
12. Peelman F., Vanloo B., Perez-Mendez O., Decout A., Verschelde J.-L., Labeur C., Vinaimont N., Verhee A., Duverger N., Brasseur R., Vandekerckhove J., Tavernier J., Rosseneu M. Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT). Protein Eng. 12:1999;71-78.
13. Adimoolam S., Jonas A. Identification of a domain of lecithin: cholesterol acyltransferase that is involved in interfacial recognition. Biochem. Biophys. Res. Commun. 232:1997;783-787.
14. Jin L., Shieh J., Grabbe E., Adimoolam S., Durbin D., Jonas A. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins. Biochemistry. 38:1999;15659-15665.
15. Peelman F., Vinaimont N., Verhee A., Vanloo B., Verschelde J.-L., Labeur C., Seguret-Mace S., Duverger N., Hutchinson G., Vandekerckhove J., Tavernier J., Rosseneu M. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling. Protein Sci. 7:1998;587-599.
16. Hengstschlager-Ottnad E., Kuchler K., Schneider W.J. Chicken lecithin-cholesterol acyltransferase. Molecular characterization reveals unusual structure and expression pattern. J. Biol. Chem. 270:1995;26139-26145.
17. Chisholm J., Gebre A., Parks J. Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase. J. Lipid Res. 40:1999;1512-1518.
18. Qu S., Fan H., Blanco-Vaca F., Pownall H. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase. J. Lipid Res. 36:1995;967-974.
19. Matz C., Jonas A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257:1982;4535-4540.
20. Dolphin P. Organic extraction and preparative isoelectric focussing of rat serum apolipoproteins. FEBS Lett. 117:1980;252-258.
21. Lee Y.-P., Adimoolam S., Liu M., Subbaiah P.V., Glenn K., Jonas A. Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation. Biochim. Biophys. Acta. 1344:1997;250-261.
22. Stokke K., Norum K. Determination of LCAT in human blood plasma. Scand. J. Clin. Lab. Invest. 27:1971;21-27.
23. Nielsen H., Engelbrecht J., Vrunak S., von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1997;1-6.
24. Nielsen H., Krogh A. Prediction of signal peptides and signal anchors by a hidden Markov model. Proc. 6th Int. Conf. On Intelligent Systems for Molecular Biology (ISMB 6). 1998;122-130 AAAI Press, Menlo Park, CA.
25. Nielsen H., Brunak S., von Heijne G. Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng. 12:1999;3-9.
26. Vanloo B., Peelman F., Deschuymere K., Taveirne J., Verhee A., Gouyette C., Labeur C., Vandekerckhove J., Tavernier J., Rosseneu M. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease. J. Lipid Res. 41:2000;752-761.
27. Peelman F., Verschelde J.-L., Vanloo B., Ampe C., Labeur C., Tavernier J. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity. J. Lipid Res. 40:1999;59-69.
28. Funke H., von Eckardstein A., Pritchard H., Albers J., Kastelein J., Droste C., Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin:cholesterol acyltransferase (LCAT) leads to the selective loss of α-LCAT activity. Proc. Natl. Acad. Sci. USA. 88:1991;4855-4859.
29. Klein H., Santamarina-Fojo S., Duverger N., Clerc M., Dumon M., Albers J., Marcovina S., Brewer B. Jr. Fish eye syndrome: a molecular defect in the lecithin:cholesterol acyltransferase (LCAT) gene associated with normal α-LCAT specific activity. J. Clin. Invest. 92:1993;479-485.
30. Kastelein J.J., Pritchard P.H., Erkelens D.W., Kuivenhoven J.A., Albers J.J., Frohlich J.J. Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent. J. Intern. Med. 231:1992;413-419.
31. Kuivenhoven J., Stalenhoef A., Hill J., Demacker P., Errami A., Kastelein J., Pritchard H. Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler. Thromb. Vasc. Biol. 16:1996;294-303.
32. Argyropoulos G., Jenkins A., Klein R., Lyons T., Wagenhorst B., St. Armand J., Marcovina S., Albers J., Pritchard H., Garvey T. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband. J. Lipid Res. 39:1998;1870-1876.
33. Holmquist L., Carlson L. α-Lecithin:cholesterol acyltransferase deficiency. Acta Med. Scand. 222:1987;23-26.
34. Skretting G., Prydz H. An amino acid exchange in exon 1 of the human lecithin:cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem. Biophys. Res. Commun. 182:1992;583-587.
35. Bolin D., Jonas A. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their lipid but not apolipoprotein composition. J. Biol. Chem. 269:1994;7429-7434.
36. Kosek A., Durbin D., Jonas A. Binding affinity and reactivity of lecithin:cholesterol acyltransferase with native lipoproteins. Biophys. Biochem. Res. Commun. 258:1999;548-551.
37. Knipping G., Hermetter A., Hubmann M.R. Interaction of N-methyl-anthraniloyl-labelled porcine apolipoprotein A-I with porcine LCAT: an energy transfer study. Int. J. Biochem. 25:1993;505-511.
38. Roosbeek S., Vanloo B., Duverger N., Caster H., Breyne J., De Beun I., Patel H., Vandekerckhove J., Shoulders C., Rosseneu M., Peelman F. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase. J. Lipid Res. 42:2001;31-40.